Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 283,601 |
|
|||||
| News | - | ||||||
| Day High | 39.86 | Low High |
|||||
| Day Low | 35.79 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 2.71 | 7.42% | 39.24 | 19:52:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 35.79 | 35.79 | 39.86 | 39.24 | 36.53 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,866 | 283,601 | $ 38.59 | $ 10,944,932 | - | 3.0334 - 49.8699 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:16:16 | 15 | $ 37.99 | USD |
Corbus Pharmaceuticals Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 410.49M | 10.49M | - | 0 | -44.6M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corbus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.65 | 45.00 | 35.19 | 39.96 | 306,693 | -0.41 | -1.03% |
| 1 Month | 37.02 | 45.00 | 33.2398 | 38.53 | 230,665 | 2.22 | 6.00% |
| 3 Months | 16.81 | 49.8699 | 16.25 | 30.07 | 1,039,391 | 22.43 | 133.43% |
| 6 Months | 6.01 | 49.8699 | 3.0334 | 29.43 | 495,520 | 33.23 | 552.91% |
| 1 Year | 11.98 | 49.8699 | 3.0334 | 28.33 | 261,591 | 27.26 | 227.55% |
| 3 Years | 50.40 | 68.70 | 2.11 | 20.35 | 1,322,777 | -11.16 | -22.14% |
| 5 Years | 207.60 | 322.50 | 2.11 | 65.00 | 2,200,005 | -168.36 | -81.10% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
